Read + Share
Okubo Y, Morishima H, Zheng R, Terui T, et al. Sustained efficacy and safety of guselkumab in patients with palmoplantar
pustulosis through 1.5 years in a randomized phase 3 study. J Dermatol 2021;48:1838-1853.
PMID: 34453358
|
 |
|
Okubo Y, Morishima H, Zheng R, Terui T, et al. Sustained efficacy and safety of guselkumab in patients with palmoplantar
pustulosis through 1.5 years in a randomized phase 3 study. J Dermatol 2021;48:1838-1853.
PMID: 34453358
|
|
|
|